Register Here

2020 Executive Sponsors

Parexel
TD2

2020 Associate Sponsors

Govig
NDA

2020 Media Partners

Big4Bio
Life Science Leader

2019 Executive Sponsors

Cytel
Exploristics
TD2

2019 Associate Sponsors

Barrington James
Govig
inSeption Group
IQVIA
NDA
Perspective
PPD Biotech
PROMETRIKA, LLC
Rho
The Higgins Group, Inc

2019 Exhibitors

NCGS
Transparency Life Sciences

2019 Supporting Sponsor

Stratacuity

The Annual Gathering for Biotech CMOs to Exchange
Best Practices, Benchmark Ideas 
and Work
Through R&D Challenges

2020 Co-Chairs Announced


The 7th annual Chief Medical Officer Summit attracted the largest gathering of physicians in biotech on April 4-5, 2019 in Boston. Although the program is primarily designed for CMOs of emerging biotech companies, large pharma CMOs and other R&D decision-makers also attended to exchange best practices in drug development and business management.

 

Key Topic Areas for 2019

  • Talent Gap in Biotech – Next steps
  • Designing Clinical Trials for Gene Therapy – a Paradigm Shift
  • Unique Development Challenges in the Microbiome
  • Immuno-Oncology: When and How to Approach Strategic Collaborations and Partnerships
  • How to De-Risk a Development Program from a Regulatory Perspective
  • Best Practices for Preparing for Investors
  • Going from Big Pharma to Small Biotech Leadership: Challenges and Opportunities
  • How to Navigate the Development Path from CMO to CEO
  • Mechanisms for CMO Performance Improvement

 

Dedicated to Accomplishing Two Goals

  1. To bring together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.
  2. To create a network of CMOs and R&D Leadership from small to mid-size life science companies to share ideas, solutions and support.

 

Recognizing the Complex Role of the Chief Medical Officer

The role of a Chief Medical Officer is one that means many things to many people, and indeed is radically different depending on the type of organization in which a CMO works. For CMOs in early, emerging and even mid-size life science companies, the role can be an isolated one, but with all the responsibility for driving the clinical development and CRO management, while meeting the needs of investors and positioning for an appropriate exit. CMOs are playing an increasingly larger role in raising funding for their life science companies.

 

Sincerely,

 

Jennifer Moran
Conference Producer

Valerie Bowling New

 

Valerie Bowling
Executive Director

Meredith-2018

Meredith Sands
Executive Director, Business Development

Elizabeth Bard
Business Development Manager

Meg

Meg Gould
Senior Conference Planner

Bre

Bre Bugbee
Marketing Manager


Testimonials

  • "It was so valuable to get to interact with so many CMOs in one place."

    - Cadmus Rich, Aura Biosciences

  • "I really enjoyed the conference, great program."

    - Christina Coughlin, Tmunity

  • "I truly enjoyed the conference. Looking forward to the next one!"

    - Martin Childers, Asklepios Biopharmaceuticals

  • "I found the interactions with other colleagues and representatives from potential external resources quite valuable."

    - John Paolini, Kiniksa Pharmaceuticals

  • "I think that CMOs can and should play a bigger and more overt role in running companies. As such it is important to me that they feel empowered and trained to do so."

    - Lauren Silverman, PhD, Managing Director, Novartis Venture Funds

  • "I found the meeting extremely useful since it was designed exclusively to addressing CMO interests. The opportunity to network with my peers at this event was invaluable since, barring this meeting, interactions I have with my peers tend to be at scientific meetings where the focus is the scientific meeting and not the CMO peer interactions."

    - Santosh Vetticaden, PhD, MD, CMO, SVP, Mast Therapeutics, Inc.

  • "It was a wonderful experience for me and I appreciate the opportunity."

    - Greg Fiore, MD, CMO, Sollis Therapeutics

  • "I thought this was one of the more valuable conferences I've attended for some time."

    - Jeffrey Moore, DPhil, MBA, VP, MP Healthcare Venture Management, Inc.

  • "I think the conference addresses an identified an under-served niche. Nice job on the conference."

    - Carl Berke, PhD, Partner, Partners Innovation Fund, Partners Healthcare and Founding Director, Mass Medical Angels

  • "These are great meetings and I applaud you for having the foresight to organize them."

    - Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH

  • "You and the Conference Forum team did a great job with this meeting. We appreciated the opportunity to work with you."

    - Paul Edgerton, Managing Partner, Gold Partners

  • "I was happy to participate and enjoyed the discussion with other panel members and interaction from the audience."

    - Chris Kiritsy, MBA, President & CEO, Arisaph

  • "The discussion at the CMO conference indicated everyone had a great time and felt that next year's event would be even bigger and better. Please extend my thanks to the entire team for putting together such a great meeting. Your team executes flawlessly each and every time. I overheard many CMO's convey this meeting was a great forum for CMO's to share ideas, challenges, frustrations, etc. in an honest, open forum (and one CMO said it was much better than a psychiatrist evaluation!)."

    - Nancy Wetherbee, MBA, Director, Office of Research Business Development in Industry Translation, Tufts Medical Center